Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Prostate|February 4, 2010
Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancerColby L Eaton, Marc Colombel, Gabri van der Pluijm, et al.
International Journal of Molecular Sciences|September 29, 2018
Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast CancerHannah K Brown, Gloria Allocca, Penelope D Ottewell, et al.
Proteomics. Clinical Applications|August 5, 2015
Prostate cancer proteomics: The urgent need for clinically validated biomarkersCaroline A Evans, Adam Glen, Colby L Eaton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivoPenelope D Ottewell, Ning Wang, Hannah K Brown, et al.
International Journal of Cancer|July 17, 2007
The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancersElizabeth A Waterman, Neil A Cross, Jenifer M Lippitt, et al.
The Prostate|September 2, 2011
Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastasesMarc Colombel, Colby L Eaton, Freddy Hamdy, et al.
The Prostate|October 12, 2013
Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progressionEstelle Ricci, Eve Mattei, Charles Dumontet, et al.
Journal of Proteome Research|February 1, 2008
iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progressionAdam Glen, Chee S Gan, Freddie C Hamdy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 19, 2015
Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancerNing Wang, Freyja Docherty, Hannah K Brown, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 21, 2015
The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancerNing Wang, Kimberley J Reeves, Hannah K Brown, et al.
Pageof 3